The DOI matches its Crossref record; 46 of the 49 references it cites were found in a registry or an index; 14 of the 28 sources its claims cite were checked for support.
Intrapatient variability of 18F-FDG uptake in normal tissues
Open accessAbstract
Retrospective study of repeat FDG PET/CT scans assessing variability in normal tissue SUVmax and confounding factors including blood glucose and BMI.
Overview
CoChat Summary
## TL;DR
This retrospective study of 167 cancer patients (334 PET/CT scans) compared test/retest variability of normal-tissue 18F-FDG uptake and found that the liver, muscle, and spleen were the most stable candidate reference tissues. Among these, spleen and muscle were judged more optimal than liver because their SUVmax was consistently associated only with injected dose, while liver SUVmax also depended on uptake duration.
## Key findings
- In 167 cancer patients with two scans on average 152 ± 68 days apart, the SUVmax of the lungs and heart differed significantly between studies (lung: 0.67 ± 0.29 vs 0.75 ± 0.37, P = 0.003; heart: 6.6 ± 5.6 vs 7.7 ± 5.7, P = 0.024), while other normal tissues did not differ significantly.
- Brain SUVmax showed the clearest glucose effect: in diabetic patients it had a moderate negative correlation with blood glucose in the first study (r = −0.537, P = 0.001), and in the whole cohort it also showed weak negative correlations with blood glucose in both studies (r = −0.245, P < 0.001; r = −0.232, P = 0.003).
- Liver SUVmax had a moderate positive correlation with BMI in both studies (r = 0.416, P < 0.001; r = 0.453, P < 0.001), and liver plus blood pool showed moderate negative correlation with uptake time in the first study only (liver r = −0.405, P < 0.001; blood pool r = −0.409, P < 0.001).
- In multivariate analysis adjusted for age, sex, BMI, and injected dose, liver SUVmax was consistently affected by injected dose and uptake duration on both occasions; spleen and muscle were consistently affected only by injected dose.
## Methods
- Retrospective review of 334 18F-FDG PET/CT scans from 167 cancer patients, including 38 diabetics; each patient had two studies, with a mean interval of 152 ± 68 days.
- Ten matched VOIs were drawn in normal tissues: brain, tonsil, blood pool, heart, lung, liver, spleen, bone marrow, fat, and iliopsoas muscle, avoiding pathology; SUVmax was measured on both occasions.
- Statistical analysis used t-tests, Pearson correlations, and multivariate analysis adjusted for age, sex, BMI, injected dose, and uptake duration.
## Limitations
- The paper explicitly states the study was retrospective and used SUVmax only according to body weight, without considering other SUV calculation methods.
- It states a larger prospective study is needed to verify the effects of high blood glucose and other confounders; this implies limited generalizability and need for confirmation.
- The text makes evident that disease burden was not included in the analysis because the authors assumed it did not affect normal-tissue uptake, which they note as another potential limitation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
7 Valid · 1 Not valid · 5 Not checked · 53 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Blood glucose level is considered among the factors that can influence the accuracy of SUVmax.”
§ Intrapatient variability of 18F-FDG uptake in normal tissues > INTRODUCTION
What the sources say
- Supportedcites [4] Eskian, 2019, Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: A systematic review and meta-analysis of 20,807 individual SUV measurements, Eur J Nucl Med Mol Imaging source
The Brain and Blood pool results (page unavailable) report significant correlations between pre-scan blood glucose level and SUVmax. This supports the broad claim that blood glucose can influence SUVmax measurements, although the direction of the relationship varies by tissue. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“However, liver SUV has been reported to show an intra-individual variability during courses of aggressive chemotherapy of some neoplasms and steroid therapy for sarcoidosis.[25,39]”
§ Intrapatient variability of 18F-FDG uptake in normal tissues > DISCUSSION > Other normal tissues
What the sources say
- Not checked — no full text of the sourcecites [25] Chiaravalloti, 2014, Factors affecting intrapatient liver and mediastinal blood pool 18 F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin’s lymphoma, Eur J Nucl Med Mol Imaging source
- Supportedcites [39] Furuya, 2018, Which is the proper reference tissue for measuring the change in FDG PET metabolic volume of cardiac sarcoidosis before and after steroid therapy?, EJNMMI Res source
The Results section, under “Differences in liver FDG uptake between pre- and mid-steroid therapies” (page not provided), reports significant increases in liver SUVmax, SUVmean, and SUVpeak during steroid therapy for cardiac sarcoidosis. This supports the steroid-therapy portion attributed to this source; the chemotherapy portion has a separate citation. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and the heart showed negligible negative correlation with the level of blood glucose in the second study only.”
§ Intrapatient variability of 18F-FDG uptake in normal tissues > RESULTS > Blood glucose level
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The liver and blood pool activities showed significant moderate negative correlation with 18F-FDG uptake time in first study only (r = −0.405, P-value = <0.001; and r = −0.409, P-value = <0.001, respectively).”
§ Intrapatient variability of 18F-FDG uptake in normal tissues > Abstract > Results
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“On subgroup analysis, the SUVmax of liver showed significant moderate positive correlation with BMI in non-diabetic patients in both studies (r = 0.482, P-value = <0.001 and r = 0.474, P-value = <0.001, respectively)”
§ Intrapatient variability of 18F-FDG uptake in normal tissues > RESULTS > BMI
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
32 more claims
Create a free account to see all 66 claims and every source verdict.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 23
Citations
Cites
Correlation Coefficients: Appropriate Use and Interpretation
Schober, P., Boer, C., & Schwarte, L. A. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002864 · Cited by 10,986
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
The glucose transporter family: structure, function and tissue-specific expression
Gould, G. W., & Holman, G. D. (1993) · Biochemical Journal · doi:10.1042/bj2950329 · Cited by 785
Joost, H.-G., & Thorens, B. (2001) · Molecular Membrane Biology · doi:10.1080/09687680110090456 · Cited by 719
Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.
Delbeke, D., Coleman, R. E., Guiberteau, M. J., Brown, M. L., Royal, H. D., Siegel, B. A., Townsend, D. W., Berland, L. L., Parker, J. A., Hubner, K., et al. (2006) · PubMed · Cited by 689
A Systematic Review of the Factors Affecting Accuracy of SUV Measurements
Adams, M. C., Turkington, T. G., Wilson, J. M., & Wong, T. Z. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4923 · Cited by 662
(2004) · PubMed · Cited by 653
Cited by
Distributable, metabolic PET reporting of tuberculosis
Khan, R. M. N., Ahn, Y., Marriner, G. A., Via, L. E., D’Hooge, F., Lee, S. S., Yang, N., Basuli, F., White, A. G., Tomko, J. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48691-6 · Cited by 29
“Uptake of FDG in the myocardium was variable among individuals and scan dates as has been noted previously 69 .”
Elsoudy, N. M., Anwar, M., Amer, H. H., Yassien, H. M., & Abdelazeez, L. M. (2024) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2024.112438 · Cited by 1
Metadata
- Authors
- Sayed, M. H. M., Abdelnaim, A. K., & Mohamadien, N. R.
- Affiliations
- Assiut University (EG)
- Corresponding author
- Sayed, Mohamed Hosny Mohamed
- Venue
- Journal of Clinical Imaging Science
- Publisher
- Scientific Scholar
- Published
- 2022-07-08
- Volume
- 12
- Pages
- 37
- ISSN
- 2156-5597 (ISSN-L)
- 2156-7514
- PMC
- PMC9479622
- OpenAlex
- W4284898578
- Cited by
- 2
- References
- 49
- Citations by year
- 2024: 2
- FWCI
- 0.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Journal of Clinical Imaging Science (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Keywords
- 18F-FDG, standardized uptake value, intrapatient variability, reference tissue, test-retest stability, serum glucose, diabetes mellitus, body mass index, liver, spleen, muscle, blood pool, PET/CT
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intrapatient variability of 18F-FDG uptake in normal tissues. https://app.cochat.ai/papers/10.25259/jcis_23_2022
- The paper
- Sayed, M. H. M., Abdelnaim, A. K., & Mohamadien, N. R. (2022). Intrapatient variability of 18F-FDG uptake in normal tissues. Journal of Clinical Imaging Science. https://doi.org/10.25259/jcis_23_2022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.